Mild to Moderate Symptoms Do Not Correlate with Lactate Levels in HIV-Positive Patients on Nucleoside Reverse Transcriptase Inhibitors

REFERENCES

• Freiman JP, Helfert KE, Hamrell MR, Stein DS. Hepatome-galy with severe steatosis in HIV seropositive patients. AIDS. 1993;7:379–385.
   PubMed Web of Science ®Google Scholar
• Chattha G, Arieff Al, Cummings C, Tierney LM Jr. Lactic acidosis complicating the acquired immunodeficiency syn-drome. Ann Intern Med. 1993;118:37–39.
   PubMed Web of Science ®Google Scholar
• ter Hofstede HJ, de Marie S, Foudraine NA, Danner SA, Brinkman K. Clinical features and risk factors of lactic acidosis following long term antiretroviral therapy: 4 fatal cases. Int J STD AIDS. 2000;11:611–616.
   PubMed Web of Science ®Google Scholar
• Antoniou T, Weisdorf T, Gough K. Symptomatic hyperlactatemia in an HIV-positive patient. Can Med Assoc J. 2002;168:195–198.
   Web of Science ®Google Scholar
• Mandelbrot L, Kermarrec N, Marcollet A, et al. Case report: nucleoside analogue-induced lactic acidosis in the third trimester of pregnancy. AIDS. 2003;17:272–273.
   PubMed Web of Science ®Google Scholar
• Carr A, Miller J, Law M, Cooper DA. A syndrome of lipoatrophy, lactic acidaemia and liver dysfunction associ-ated with HIV nucleoside analogue therapy: contribution to protease inhibitor-related lipodystrophy syndrome. AIDS. 2000;14:F25–F32.
   PubMed Web of Science ®Google Scholar
• Fortgang IS, Belitsos PC, Chaisson RE, Moore RD. Hepatomegaly and steatosis in HIV infected patients re-ceiving nucleoside analogue antiretroviral therapy. Am J Gastroenterol. 1995;90:1433–1446.
   PubMed Web of Science ®Google Scholar
• Coghlan ME, Sommadossi J-P, Jhala NC, Many WJ, Saag MS, Johnson VA. Symptomatic lactic acidosis in hospital-ized antiretroviral-treated patients with Human Immunode-ficiency Virus infection: a report of 12 cases. Clin Infect Dis. 2001;33:1914–1921.
   PubMed Web of Science ®Google Scholar
• Brinkman K, ter Hofstede HJ. Mitochondrial toxicity of nucleoside analogue reverse transcriptase inhibitors: lactic acidosis, risk factors and therapeutic options. AIDS Rev. 1999;1:141–148.
   Google Scholar
• Falco V, Rodriguez D, Ribera E et al. Severe nucleoside-associated lactic acidosis in Human Immunodeficiency Vi-rus-infected patients: report of 12 cases and review of the literature. Clin Infect Dis. 2002;34:838–846.
   PubMed Web of Science ®Google Scholar
• Lewis W, Dalakas MC. Mitochondrial toxicity of antiviral drugs. Nat Med. 1995;1:417–421.
   PubMed Web of Science ®Google Scholar
• Brinkman K, ter Hofstede HJM, Burger DM, Smeitink JA, Koopmans PP. Adverse effects of reverse transcriptase inhibitors: mitochondrial toxicity as common pathway. AIDS. 1998;12:1735–1744.
   PubMed Web of Science ®Google Scholar
• John M, Moore CB, James IR, et al. Chronic hyperlactatemia in HIV infected patients taking antiretroviral therapy. AIDS. 200115: 717–723.
   Google Scholar
• Tripuraneni NS, Smith PR, Weedon J, Rosa U, Sepkowitz D. Prognostic factors in lactic acidosis syndrome caused by nucleoside reverse transcriptase inhibitors: report of eight cases and review of the literature. AIDS Patient Care STDs. 2004;18:379–384.
   PubMed Web of Science ®Google Scholar
• Imhof A, Ledergerber B, Günthard HF, Haupts S, Weber R, Swiss HIV Cohort Study. Risk factors for and outcome of hyperlactatemia in HIV-infected persons: Is there a need for routine lactate monitoring? Clin Infect Dis. 2005;41: 721–728.
   PubMed Web of Science ®Google Scholar
• Brinkman K. Editorial response: hyperlactatemia and he-patic steatosis as features of mitochondrial toxicity of nucleoside analogue reverse transcriptase inhibitors. Clin Infect Dis. 2000;31:167–169.
   PubMed Web of Science ®Google Scholar
• Brinkman K. Management of hyperlactatemia: no need for routine lactate measurements. AIDS. 2001;15:795–797.
   PubMed Web of Science ®Google Scholar
• Gerard Y, Maulin L, Yazdanpanah Y, et al. Symptomatic hyperlactatemia: an emerging complication of antiretroviral therapy. AIDS. 2000;14:2723–2730.
   PubMed Web of Science ®Google Scholar
• John M, Melia! S. Hyperlactatemia syndromes in people with HIV infection. Curr Opin Infect Dis. 2002;15:23–29.
   PubMed Web of Science ®Google Scholar
• Loneragan JT, Behling C, Pfander H, Hassanein TI, Mathews WC. Hyperlactatemia and hepatic abnormalities in 10 HIV infected patients receiving nucleoside analogue combination regimens. Clin Infect Dis. 2000;31:162–166.
   PubMed Web of Science ®Google Scholar
• Chariot P, Ratiney R, Ammi-Said M, Herigault R, Adnot S, Gherardi R. Optimal handling of blood samples for routine measurement of lactate and pyruvate. Arch Pathol Lab Med. 1994;118:695–697.
   PubMed Web of Science ®Google Scholar
• Astles R, Williams CP, Sedor F. Stability of plasma lactate in vitro in the presence of antiglycolytic agents. Clin Chem. 1994;40:1327–1330.
   PubMed Web of Science ®Google Scholar
• Zala C, Harris M, Ochoa C, et al. Venous and arterial blood lactate in HIV-infected patients [letter]. Antivir Ther. 2002;7:309–310.
   PubMed Web of Science ®Google Scholar
• Foli A, Benvenuto F, Piccinini F, et al. Direct analysis of mitochondrial toxicity of antiretroviral drugs. AIDS. 200115:1687–1694.
   Google Scholar
• Cote HCF, Brumme ZL, Craib KJP, et al. Changes in mito-chondria! DNA as a marker of nucleoside toxicity in HIV-infected patients. N Engl J Med. 2002;346:811–820.
   PubMed Web of Science ®Google Scholar
• Shikuma CM, Hu N, Milne C, et al. Mitochondria! DNA decrease in subcutaneous adipose tissue of HIV-infected individuals with peripheral lipoatrophy. AIDS. 200115:1801–1809.
   Google Scholar
• Gahan ME, Miller F, Lewin SR, et al. Quantification of mitochondria! DNA in peripheral blood mononuclear cells and subcutaneous fat using real-time polymerase chain reaction. J Clin Virol. 200122: 241–247.
   Google Scholar
• Nolan D, Hammond E, Martin A, et al. Mitochondria! DNA depletion and morphologic changes in adipocytes associ-ated with nucleoside reverse transcriptase inhibitor therapy. AIDS. 2003;17:1329–1338.
   PubMed Web of Science ®Google Scholar
• Montaner JSG, Cote HCF, Harris M, et al. Mitochondrial toxicty in the era of HAART: evaluating venous lactate and peripheral blood mitochondria! DNA in HIV-infected pa-tients taking antiretroviral therapy. J Acquir Immune Defic Syndr. 2003;34:585–90.
   Web of Science ®Google Scholar
• Cossarizza A, Pinti M, Moretti L, et al. Mitochondrial func-tionality and mitochondria! DNA content in lymphocytes of vertically infected Human Immunodeficiency Virus-positive children with highly active antiretroviral therapy-related li-podystrophy. J Infect Dis. 2002;185:299–305.
   PubMed Web of Science ®Google Scholar
• Blanche S, Tardieu M, Rustin P, et al. Persistent mitochon-drial dysfunction and perinatal exposure to antiretroviral nucleoside analogues. Lancet. 1999;354:1084–1089.
   PubMed Web of Science ®Google Scholar
• McComsey G, Tan DJ, Lederman M, Wilson E, Wong U. Analysis of the mitochondria! DNA genome in the periph-eral blood leukocytes of HIV-infected patients with or with-out lipoatrophy. AIDS. 2002;16:513–518.
   PubMed Web of Science ®Google Scholar
• Walker UA, Setzer B, Venhoff N. Increased long-term mito-chondrial toxicity in combinations of nucleoside analogue reverse-transcriptase inhibitors. AIDS. 200216: 2165–2173.
   Google Scholar
• Mokryzycki MH, Harris C, May H, Laut J, Palmisano J. Lactic acidosis associated with stavudine administration: a report of five cases. Clin Infect Dis. 2000;30:198–200.
   PubMed Web of Science ®Google Scholar
• Boubaker K, Flepp M, Sudre P, et al. Hyperlactatemia and antiretroviral therapy: the Swiss HIV Cohort Study. Clin Infect Dis. 2001;33:1931–1937.
   PubMed Web of Science ®Google Scholar
• Lai KK, Gang DL, Zawacki JK, Cooley TP. Fulminant he-patic failure associated with 2',3'-dideoxyinosine (ddl). Ann Intern Med. 1991115: 283–284.
   Google Scholar
• Moyle GJ, Datta D, Mandalia S, Morlese J, Asboe D, Gazzard BG. Hyperlactatemia and lactic acidosis during antiretroviral therapy: relevance, reproducibility and pos-sible risk factors. AIDS. 2002;16:1341–1349.
   PubMed Web of Science ®Google Scholar
• Olano JP, Borucki MJ, Wen JW, Hague AK. Massive he-patic steatosis and lactic acidosis in a patient with AIDS who was receiving zidovudine. Clin Infect Dis. 1995;21:973–976.
   PubMed Web of Science ®Google Scholar